Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04184973Not ApplicableRecruiting

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

Role: lead

NCT05632744Not ApplicableRecruiting

Evaluation of CG-100 Intraluminal Bypass Device

Role: lead

NCT03423485Not ApplicableUnknown

Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.

Role: lead

NCT02109991Not ApplicableCompleted

Safety, Tolerability and Performance Profile of the Colospan Device CG-100 in Patients Undergoing Colorectal Surgery

Role: lead

All 4 trials loaded